Medical Care
Global Allergy Immunotherapies Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 198363
- Pages: 72
- Figures: 68
- Views: 2
The global Allergy Immunotherapies market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
The global Allergy Immunotherapies market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
ALK
Stallergenes
HAL
By Type: (Dominant Segment vs High-Margin Innovation)
Subcutaneous Immunotherapy
Sublingual Immunotherapy
By Application: (Core Demand Driver vs Emerging Opportunity)
Allergic Rhinitis
Allergic Asthma
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., ALK in Europe)
- Emerging Product Trends: Subcutaneous Immunotherapy adoption vs. Sublingual Immunotherapy premiumization
- Demand-Side Dynamics: Allergic Rhinitis growth in China vs. Allergic Asthma potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Allergy Immunotherapies market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Sublingual Immunotherapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Allergic Asthma in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Allergy Immunotherapies value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
The global Allergy Immunotherapies market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
ALK
Stallergenes
HAL
By Type: (Dominant Segment vs High-Margin Innovation)
Subcutaneous Immunotherapy
Sublingual Immunotherapy
By Application: (Core Demand Driver vs Emerging Opportunity)
Allergic Rhinitis
Allergic Asthma
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., ALK in Europe)
- Emerging Product Trends: Subcutaneous Immunotherapy adoption vs. Sublingual Immunotherapy premiumization
- Demand-Side Dynamics: Allergic Rhinitis growth in China vs. Allergic Asthma potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Allergy Immunotherapies market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Sublingual Immunotherapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Allergic Asthma in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Allergy Immunotherapies value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergy Immunotherapies Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Allergy Immunotherapies Revenue Market Share by Region (2020-2025)
2.4 Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.2 Europe Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.3 China Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.4 Japan Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.6 India Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.7 Central & South America Allergy Immunotherapies Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Allergy Immunotherapies Historic Market Size by Type (2020-2025)
3.2 Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031)
3.3 Different Types Allergy Immunotherapies Representative Players
4 Breakdown Data by Application
4.1 Global Allergy Immunotherapies Historic Market Size by Application (2020-2025)
4.2 Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Allergy Immunotherapies Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Allergy Immunotherapies Players by Revenue (2020-2025)
5.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Allergy Immunotherapies Revenue
5.4 Global Allergy Immunotherapies Market Concentration Analysis
5.4.1 Global Allergy Immunotherapies Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Allergy Immunotherapies Revenue in 2024
5.5 Global Key Players of Allergy Immunotherapies Head office and Area Served
5.6 Global Key Players of Allergy Immunotherapies, Product and Application
5.7 Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Allergy Immunotherapies Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Allergy Immunotherapies Market Size by Type (2020-2025)
6.1.2.2 North America Allergy Immunotherapies Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Allergy Immunotherapies Market Size by Application (2020-2025)
6.1.3.2 North America Allergy Immunotherapies Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Allergy Immunotherapies Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Allergy Immunotherapies Market Size by Type (2020-2025)
6.2.2.2 Europe Allergy Immunotherapies Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Allergy Immunotherapies Market Size by Application (2020-2025)
6.2.3.2 Europe Allergy Immunotherapies Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Allergy Immunotherapies Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Allergy Immunotherapies Market Size by Type (2020-2025)
6.3.2.2 China Allergy Immunotherapies Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Allergy Immunotherapies Market Size by Application (2020-2025)
6.3.3.2 China Allergy Immunotherapies Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Allergy Immunotherapies Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Allergy Immunotherapies Market Size by Type (2020-2025)
6.4.2.2 Japan Allergy Immunotherapies Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Allergy Immunotherapies Market Size by Application (2020-2025)
6.4.3.2 Japan Allergy Immunotherapies Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Allergy Immunotherapies Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Allergy Immunotherapies Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Allergy Immunotherapies Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Allergy Immunotherapies Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Allergy Immunotherapies Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Allergy Immunotherapies Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Allergy Immunotherapies Market Size by Type (2020-2025)
6.6.2.2 India Allergy Immunotherapies Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Allergy Immunotherapies Market Size by Application (2020-2025)
6.6.3.2 India Allergy Immunotherapies Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 ALK
7.1.1 ALK Company Details
7.1.2 ALK Business Overview
7.1.3 ALK Allergy Immunotherapies Introduction
7.1.4 ALK Revenue in Allergy Immunotherapies Business (2020-2025)
7.1.5 ALK Recent Development
7.2 Stallergenes
7.2.1 Stallergenes Company Details
7.2.2 Stallergenes Business Overview
7.2.3 Stallergenes Allergy Immunotherapies Introduction
7.2.4 Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025)
7.2.5 Stallergenes Recent Development
7.3 HAL
7.3.1 HAL Company Details
7.3.2 HAL Business Overview
7.3.3 HAL Allergy Immunotherapies Introduction
7.3.4 HAL Revenue in Allergy Immunotherapies Business (2020-2025)
7.3.5 HAL Recent Development
8 Allergy Immunotherapies Market Dynamics
8.1 Allergy Immunotherapies Industry Trends
8.2 Allergy Immunotherapies Market Drivers
8.3 Allergy Immunotherapies Market Challenges
8.4 Allergy Immunotherapies Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergy Immunotherapies Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Allergy Immunotherapies Revenue Market Share by Region (2020-2025)
2.4 Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.2 Europe Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.3 China Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.4 Japan Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.6 India Allergy Immunotherapies Market Size and Prospective (2020-2031)
2.5.7 Central & South America Allergy Immunotherapies Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Allergy Immunotherapies Historic Market Size by Type (2020-2025)
3.2 Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031)
3.3 Different Types Allergy Immunotherapies Representative Players
4 Breakdown Data by Application
4.1 Global Allergy Immunotherapies Historic Market Size by Application (2020-2025)
4.2 Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Allergy Immunotherapies Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Allergy Immunotherapies Players by Revenue (2020-2025)
5.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Allergy Immunotherapies Revenue
5.4 Global Allergy Immunotherapies Market Concentration Analysis
5.4.1 Global Allergy Immunotherapies Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Allergy Immunotherapies Revenue in 2024
5.5 Global Key Players of Allergy Immunotherapies Head office and Area Served
5.6 Global Key Players of Allergy Immunotherapies, Product and Application
5.7 Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Allergy Immunotherapies Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Allergy Immunotherapies Market Size by Type (2020-2025)
6.1.2.2 North America Allergy Immunotherapies Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Allergy Immunotherapies Market Size by Application (2020-2025)
6.1.3.2 North America Allergy Immunotherapies Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Allergy Immunotherapies Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Allergy Immunotherapies Market Size by Type (2020-2025)
6.2.2.2 Europe Allergy Immunotherapies Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Allergy Immunotherapies Market Size by Application (2020-2025)
6.2.3.2 Europe Allergy Immunotherapies Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Allergy Immunotherapies Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Allergy Immunotherapies Market Size by Type (2020-2025)
6.3.2.2 China Allergy Immunotherapies Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Allergy Immunotherapies Market Size by Application (2020-2025)
6.3.3.2 China Allergy Immunotherapies Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Allergy Immunotherapies Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Allergy Immunotherapies Market Size by Type (2020-2025)
6.4.2.2 Japan Allergy Immunotherapies Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Allergy Immunotherapies Market Size by Application (2020-2025)
6.4.3.2 Japan Allergy Immunotherapies Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Allergy Immunotherapies Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Allergy Immunotherapies Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Allergy Immunotherapies Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Allergy Immunotherapies Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Allergy Immunotherapies Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Allergy Immunotherapies Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Allergy Immunotherapies Market Size by Type (2020-2025)
6.6.2.2 India Allergy Immunotherapies Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Allergy Immunotherapies Market Size by Application (2020-2025)
6.6.3.2 India Allergy Immunotherapies Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 ALK
7.1.1 ALK Company Details
7.1.2 ALK Business Overview
7.1.3 ALK Allergy Immunotherapies Introduction
7.1.4 ALK Revenue in Allergy Immunotherapies Business (2020-2025)
7.1.5 ALK Recent Development
7.2 Stallergenes
7.2.1 Stallergenes Company Details
7.2.2 Stallergenes Business Overview
7.2.3 Stallergenes Allergy Immunotherapies Introduction
7.2.4 Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025)
7.2.5 Stallergenes Recent Development
7.3 HAL
7.3.1 HAL Company Details
7.3.2 HAL Business Overview
7.3.3 HAL Allergy Immunotherapies Introduction
7.3.4 HAL Revenue in Allergy Immunotherapies Business (2020-2025)
7.3.5 HAL Recent Development
8 Allergy Immunotherapies Market Dynamics
8.1 Allergy Immunotherapies Industry Trends
8.2 Allergy Immunotherapies Market Drivers
8.3 Allergy Immunotherapies Market Challenges
8.4 Allergy Immunotherapies Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Allergy Immunotherapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Allergy Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Allergy Immunotherapies Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Allergy Immunotherapies Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Allergy Immunotherapies Revenue Share by Region (2020-2025)
Table 6. Global Allergy Immunotherapies Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Allergy Immunotherapies Revenue Share Forecast by Region (2026-2031)
Table 8. Global Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Table 10. Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Allergy Immunotherapies Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Table 15. Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Allergy Immunotherapies Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Allergy Immunotherapies Application
Table 18. Global Allergy Immunotherapies Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Allergy Immunotherapies Market Share by Players (2020-2025)
Table 20. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Table 21. Ranking of Global Top Allergy Immunotherapies Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Allergy Immunotherapies Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Allergy Immunotherapies, Headquarters and Area Served
Table 24. Global Key Players of Allergy Immunotherapies, Product and Application
Table 25. Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 29. North America Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 33. Europe Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 37. China Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 41. Japan Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 49. India Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 51. ALK Company Details
Table 52. ALK Business Overview
Table 53. ALK Allergy Immunotherapies Product
Table 54. ALK Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 55. ALK Recent Development
Table 56. Stallergenes Company Details
Table 57. Stallergenes Business Overview
Table 58. Stallergenes Allergy Immunotherapies Product
Table 59. Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 60. Stallergenes Recent Development
Table 61. HAL Company Details
Table 62. HAL Business Overview
Table 63. HAL Allergy Immunotherapies Product
Table 64. HAL Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 65. HAL Recent Development
Table 66. Allergy Immunotherapies Market Trends
Table 67. Allergy Immunotherapies Market Drivers
Table 68. Allergy Immunotherapies Market Challenges
Table 69. Allergy Immunotherapies Market Restraints
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Immunotherapies Product Picture
Figure 2. Global Allergy Immunotherapies Market Share by Type: 2024 VS 2031
Figure 3. Subcutaneous Immunotherapy Features
Figure 4. Sublingual Immunotherapy Features
Figure 5. Global Allergy Immunotherapies Market Share by Application: 2024 VS 2031
Figure 6. Allergic Rhinitis
Figure 7. Allergic Asthma
Figure 8. Other
Figure 9. Allergy Immunotherapies Report Years Considered
Figure 10. Global Allergy Immunotherapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Allergy Immunotherapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Allergy Immunotherapies Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Central & South America Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Allergy Immunotherapies Market Share by Players in 2024
Figure 21. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Allergy Immunotherapies Revenue in 2024
Figure 23. North America Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 24. North America Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 25. Europe Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 26. Europe Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 27. China Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 28. China Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 29. Japan Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 30. Japan Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 31. Southeast Asia Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 32. Southeast Asia Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 33. India Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 34. India Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 35. ALK Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 36. Stallergenes Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 37. HAL Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
Table 1. Global Allergy Immunotherapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Allergy Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Allergy Immunotherapies Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Allergy Immunotherapies Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Allergy Immunotherapies Revenue Share by Region (2020-2025)
Table 6. Global Allergy Immunotherapies Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Allergy Immunotherapies Revenue Share Forecast by Region (2026-2031)
Table 8. Global Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Table 10. Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Allergy Immunotherapies Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Table 15. Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Allergy Immunotherapies Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Allergy Immunotherapies Application
Table 18. Global Allergy Immunotherapies Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Allergy Immunotherapies Market Share by Players (2020-2025)
Table 20. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Table 21. Ranking of Global Top Allergy Immunotherapies Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Allergy Immunotherapies Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Allergy Immunotherapies, Headquarters and Area Served
Table 24. Global Key Players of Allergy Immunotherapies, Product and Application
Table 25. Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 29. North America Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 33. Europe Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 37. China Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 41. Japan Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Allergy Immunotherapies Revenue Market Share by Company (2020-2025)
Table 49. India Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 51. ALK Company Details
Table 52. ALK Business Overview
Table 53. ALK Allergy Immunotherapies Product
Table 54. ALK Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 55. ALK Recent Development
Table 56. Stallergenes Company Details
Table 57. Stallergenes Business Overview
Table 58. Stallergenes Allergy Immunotherapies Product
Table 59. Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 60. Stallergenes Recent Development
Table 61. HAL Company Details
Table 62. HAL Business Overview
Table 63. HAL Allergy Immunotherapies Product
Table 64. HAL Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 65. HAL Recent Development
Table 66. Allergy Immunotherapies Market Trends
Table 67. Allergy Immunotherapies Market Drivers
Table 68. Allergy Immunotherapies Market Challenges
Table 69. Allergy Immunotherapies Market Restraints
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Immunotherapies Product Picture
Figure 2. Global Allergy Immunotherapies Market Share by Type: 2024 VS 2031
Figure 3. Subcutaneous Immunotherapy Features
Figure 4. Sublingual Immunotherapy Features
Figure 5. Global Allergy Immunotherapies Market Share by Application: 2024 VS 2031
Figure 6. Allergic Rhinitis
Figure 7. Allergic Asthma
Figure 8. Other
Figure 9. Allergy Immunotherapies Report Years Considered
Figure 10. Global Allergy Immunotherapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Allergy Immunotherapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Allergy Immunotherapies Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Central & South America Allergy Immunotherapies Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Allergy Immunotherapies Market Share by Players in 2024
Figure 21. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Allergy Immunotherapies Revenue in 2024
Figure 23. North America Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 24. North America Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 25. Europe Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 26. Europe Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 27. China Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 28. China Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 29. Japan Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 30. Japan Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 31. Southeast Asia Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 32. Southeast Asia Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 33. India Allergy Immunotherapies Market Share by Type (2020-2025)
Figure 34. India Allergy Immunotherapies Market Share by Application (2020-2025)
Figure 35. ALK Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 36. Stallergenes Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 37. HAL Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232